← FDA Drug Approvals (Drugs@FDA)
RIFABUTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2014-02-24
Drug application
- FDA Application #
ANDA090033- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIFABUTIN
- Generic name
- Rifabutin
- Active ingredients
- RIFABUTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LUPIN
- First approval
- 2014-02-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown